Logo image of MTEN

MINGTENG INTERNATIONAL CORP (MTEN) Stock Fundamental Analysis

NASDAQ:MTEN - KYG6S85D1097 - Common Stock

12 USD
+0.05 (+0.42%)
Last: 9/3/2025, 8:00:01 PM
Fundamental Rating

2

Taking everything into account, MTEN scores 2 out of 10 in our fundamental rating. MTEN was compared to 80 industry peers in the Automobile Components industry. While MTEN seems to be doing ok healthwise, there are quite some concerns on its profitability. MTEN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

MTEN had negative earnings in the past year.
MTEN had a positive operating cash flow in the past year.
MTEN Yearly Net Income VS EBIT VS OCF VS FCFMTEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M -2M -4M

1.2 Ratios

MTEN has a worse Return On Assets (-42.58%) than 93.75% of its industry peers.
MTEN has a Return On Equity of -70.32%. This is amonst the worse of the industry: MTEN underperforms 88.75% of its industry peers.
Industry RankSector Rank
ROA -42.58%
ROE -70.32%
ROIC N/A
ROA(3y)-1.81%
ROA(5y)N/A
ROE(3y)-3.94%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MTEN Yearly ROA, ROE, ROICMTEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 40 -40 -60

1.3 Margins

MTEN has a better Gross Margin (31.96%) than 91.25% of its industry peers.
In the last couple of years the Gross Margin of MTEN has declined.
MTEN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.42%
GM growth 5YN/A
MTEN Yearly Profit, Operating, Gross MarginsMTEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20 40 -40

4

2. Health

2.1 Basic Checks

MTEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MTEN has more shares outstanding
MTEN has a worse debt/assets ratio than last year.
MTEN Yearly Shares OutstandingMTEN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M
MTEN Yearly Total Debt VS Total AssetsMTEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

An Altman-Z score of 9.14 indicates that MTEN is not in any danger for bankruptcy at the moment.
MTEN's Altman-Z score of 9.14 is amongst the best of the industry. MTEN outperforms 93.75% of its industry peers.
A Debt/Equity ratio of 0.16 indicates that MTEN is not too dependend on debt financing.
MTEN's Debt to Equity ratio of 0.16 is amongst the best of the industry. MTEN outperforms 86.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 9.14
ROIC/WACCN/A
WACC8.33%
MTEN Yearly LT Debt VS Equity VS FCFMTEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M 4M 6M 8M

2.3 Liquidity

MTEN has a Current Ratio of 1.64. This is a normal value and indicates that MTEN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of MTEN (1.64) is worse than 81.25% of its industry peers.
A Quick Ratio of 1.42 indicates that MTEN should not have too much problems paying its short term obligations.
MTEN has a Quick ratio of 1.42. This is amongst the best in the industry. MTEN outperforms 82.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.42
MTEN Yearly Current Assets VS Current LiabilitesMTEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M

3

3. Growth

3.1 Past

The earnings per share for MTEN have decreased strongly by -345.02% in the last year.
The Revenue has grown by 24.15% in the past year. This is a very strong growth!
The Revenue has been growing by 9.39% on average over the past years. This is quite good.
EPS 1Y (TTM)-345.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-420.31%
Revenue 1Y (TTM)24.15%
Revenue growth 3Y9.39%
Revenue growth 5YN/A
Sales Q2Q%23.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MTEN Yearly Revenue VS EstimatesMTEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2M 4M 6M 8M 10M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MTEN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MTEN Price Earnings VS Forward Price EarningsMTEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MTEN Per share dataMTEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MTEN!.
Industry RankSector Rank
Dividend Yield N/A

MINGTENG INTERNATIONAL CORP

NASDAQ:MTEN (9/3/2025, 8:00:01 PM)

12

+0.05 (+0.42%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.43%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap82.08M
AnalystsN/A
Price TargetN/A
Short Float %21.56%
Short Ratio4.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.56
P/FCF N/A
P/OCF 278.24
P/B 9.71
P/tB 9.79
EV/EBITDA N/A
EPS(TTM)-1.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)0.04
OCFY0.36%
SpS2.16
BVpS1.24
TBVpS1.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -42.58%
ROE -70.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.96%
FCFM N/A
ROA(3y)-1.81%
ROA(5y)N/A
ROE(3y)-3.94%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.42%
GM growth 5YN/A
F-Score3
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 188%
Cap/Sales 6.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 1.42
Altman-Z 9.14
F-Score3
WACC8.33%
ROIC/WACCN/A
Cap/Depr(3y)224.73%
Cap/Depr(5y)N/A
Cap/Sales(3y)12.3%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-345.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-420.31%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)24.15%
Revenue growth 3Y9.39%
Revenue growth 5YN/A
Sales Q2Q%23.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-322.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-227.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-77.31%
OCF growth 3Y-41.7%
OCF growth 5YN/A